Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric Attention Deficit Hyperactivity Disorder”

100 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 100 results

Testing effectiveness (Phase 2)Study completedNCT00466791
What this trial is testing

Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD

Who this might be right for
Attention Deficit Disorder With Hyperactivity
Noven Therapeutics 93
Early research (Phase 1)Study completedNCT02195167
What this trial is testing

Dasotraline SEP360-105 Pediatric PK/PD Study

Who this might be right for
Pediatric Attention Deficit Hyperactivity Disorder
Sumitomo Pharma America, Inc. 105
Large-scale testing (Phase 3)Study completedNCT00922636
What this trial is testing

Pediatric Patients With Attention Deficit/Hyperactivity Disorder

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 340
Not applicableStudy completedNCT03190902
What this trial is testing

Cognitive Impairment in Pediatric Onset Multiple Sclerosis

Who this might be right for
Pediatric Onset Multiple SclerosisADHD Predominantly Inattentive Type
Pietro Iaffaldano 36
Not applicableWithdrawnNCT01769300
What this trial is testing

Improving the Medication Management of Patients With Attention-Deficit Hyperactivity Disorder

Who this might be right for
Attention Deficit-hyperactivity Disorder
American Academy of Pediatrics
Large-scale testing (Phase 3)Study completedNCT00486083
What this trial is testing

Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHD

Who this might be right for
Attention Deficit Hyperactivity Disorder
Eli Lilly and Company 330
Not applicableStudy completedNCT03104972
What this trial is testing

Non-invasive Brain Stimulation for Pediatric ADHD

Who this might be right for
ADHD
Hebrew University of Jerusalem 47
Not applicableLooking for participantsNCT03221244
What this trial is testing

Virtual Reality Attention Management

Who this might be right for
ADHD
University of California, Davis 50
Not applicableStudy completedNCT02828644
What this trial is testing

Software Treatment for Actively Reducing Severity of ADHD - Follow Up

Who this might be right for
Attention Deficit Disorder With Hyperactivity
Akili Interactive Labs, Inc. 175
Large-scale testing (Phase 3)Study completedNCT02428088
What this trial is testing

Dasotraline Pediatric ADHD Study

Who this might be right for
Attention Deficit Hyperactivity Disorder
Sumitomo Pharma America, Inc. 330
Not applicableStudy completedNCT07586761
What this trial is testing

The Effects of Lemon Essential Oil Inhalation on Attention in Children With Attention Deficit Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit Disorder With Hyperactivity (ADHD)Sustained AttentionAromatherapy+2 more
Başakşehir Çam & Sakura City Hospital 52
Large-scale testing (Phase 3)Ended earlyNCT02691182
What this trial is testing

Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 4)

Who this might be right for
Attention Deficit Hyperactivity Disorder (ADHD)
Supernus Pharmaceuticals, Inc. 491
Not applicableLooking for participantsNCT04946253
What this trial is testing

SKIP for PA Study: Team and Leadership Level Implementation Support for Collaborative Care

Who this might be right for
Child Behavior ProblemAttention Deficit and Disruptive Behavior Disorders
University of Pittsburgh 450
Post-approval studies (Phase 4)Study completedNCT04152629
What this trial is testing

Real World Evidence of the Efficacy and Safety of FOQUEST

Who this might be right for
Attention Deficit-Hyperactivity Disorder
Purdue Pharma, Canada 257
Not applicableStudy completedNCT00646464
What this trial is testing

New Continuous Performance Tests (CPT) for the Diagnosis of Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)

Who this might be right for
Attention Deficit Hyperactivity Disorder
Hadassah Medical Organization 500
Post-approval studies (Phase 4)Ended earlyNCT04987762
What this trial is testing

Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children

Who this might be right for
Attention Deficit/Hyperactivity Disorder
Purdue Pharma LP 103
Not applicableEnrolling By InvitationNCT07216638
What this trial is testing

Pediatric Behavioral Health Integrated Care: Indiana Statewide Strategic Plan to Address the Growing Mental Health Crisis

Who this might be right for
Implementation ResearchDepressive DisorderANXIETY DISORDERS (or Anxiety and Phobic Neuroses)+2 more
Indiana University 575
Early research (Phase 1)Study completedNCT04398225
What this trial is testing

A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine in Pediatric Subjects With Attention-deficit/Hyperactivity Disorder

Who this might be right for
Attention Deficit Hyperactivity Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 32
Post-approval studies (Phase 4)Study completedNCT01933880
What this trial is testing

A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive Functions of Attention Deficit Hyperactivity Disorder (ADHD) Participants

Who this might be right for
Attention Deficit Hyperactivity Disorder (ADHD)
Xian-Janssen Pharmaceutical Ltd. 194
Large-scale testing (Phase 3)Study completedNCT02457819
What this trial is testing

Dasotraline Pediatric Extension Study

Who this might be right for
Attention Deficit Hyperactivity Disorder
Sumitomo Pharma America, Inc. 237
Next Page